title: Evidence suggesting the presence of a stem cell clone anteceding the acquisition of the JAK2-V617F mutation.
authors.forename: R
authors.initials: R
authors.lastname: Jamal
authors.forename: C
authors.initials: C
authors.lastname: Bélisle
authors.forename: M-C
authors.initials: MC
authors.lastname: Lessard
authors.forename: J
authors.initials: J
authors.lastname: Hébert
authors.forename: D-C
authors.initials: DC
authors.lastname: Roy
authors.forename: R
authors.initials: R
authors.lastname: Levine
authors.forename: L
authors.initials: L
authors.lastname: Busque
mesh_terms: D006410:Hematopoiesis; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D053614:Janus Kinase 2 / Q000235:genetics*; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009154:Mutation; D012008:Recurrence; D018183:Transplantation Chimera; D014184:Transplantation, Homologous
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2; D006918:Hydroxyurea